Morinda Colon Cleanse
Natural health product licensed in Canada
- Licence holder
- Partner.Co Canada
- NPN or DIN-HM
- 80079330
- Status
- Active licence
- Licence date
- 3 August 2017
- Revision date
- 26 July 2023
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Aloe vera (L.) Burm. f.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zingiber officinale Source : Zingiber officinale - racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 120 milligramme | 30 milligramme | Not calculated |
| Glycyrrhiza glabra Source : Glycyrrhiza glabra - racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 260 milligramme | 65 milligramme | Not calculated |
| Aloe vera Source : Aloe vera - Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 25 milligramme | 6.25 milligramme | Not calculated |
| Taraxacum officinale Source : Taraxacum officinale - Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 20 milligramme | 5 milligramme | Not calculated |
| Juniperus communis Source : Juniperus communis - Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 120 milligramme | 30 milligramme | Not calculated |
| Capsicum annuum Source : Capsicum annuum - fruit | 6.25 milligramme | Not calculated |
| Pectine Source : Citrus limon - Pelure (fruit) | 6.25 milligramme | Not calculated |
| Plantago ovata Source : Plantago ovata husk | 150 milligramme | Not calculated |
| Cucurbita pepo Source : Cucurbita pepo - Graine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 380 milligramme | 95 milligramme | Not calculated |
| Arctium lappa Source : Arctium lappa - racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 300 milligramme | 30 milligramme | Not calculated |
| Avena sativa Source : Avena sativa - son (grain) | 6.25 milligramme | Not calculated |
| Prunus domestica Source : Prunus domestica - Fruit | 6.25 milligramme | Not calculated |
| Linum usitatissimum Source : Linum usitatissimum - Graine | 6.25 milligramme | Not calculated |
Non-medicinal ingredients
Maltodextrine, farine de riz, Hypromellose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 day |
Uses authorised in Canada
Traditionally used in Herbal Medicine to help relieve inflammatory conditions of the gastrointestinal tract such as gastritis in adults. Used in Herbal medicine as a stimulant laxative. Used in Herbal medicine for short-term relief of occasional constipation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity, such as an allergy, has been known to occur; in which case, discontinue use.
- Contre-indications
Do not use if you are taking thiazide diuretics, cardiac glycosides, corticosteroids, stimulant laxatives or other medications which may aggravate electrolyte imbalance. Do not use if you have hypokalemia, high blood pressure, or a kidney or cardiovascular disorder. Do not use if you are pregnant or breastfeeding. Do not use if you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease (e.g. Crohn's disease or ulcerative colitis), abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes, hemorrhoids or diarrhoea.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner prior to use if you are pregnant. Consult a health care practitioner prior to use if you have a liver disorder. Consult a health care practitioner prior to use if you are taking thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. Consult a health care practitioner prior to use if you have a kidney disorder, or are taking cardiac medications (e.g. cardiac glycosides or antiarrhythmic medications). Consult a health care practitioner prior to use if you have faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever. Reduce dose or discontinue use if you experience abdominal pain, cramps, spasms and/or diarrhoea. Consult a health care practitioner immediately if you experience chest pain, vomiting or difficulty swallowing or breathing after taking this product. Consult a health care practitioner prior to use if you are experiencing a sudden change in bowel habits that have persisted for more than two weeks, undiagnosed rectal bleeding, or have failed to defecate following the use of a laxative product. Consult a health care practitioner if you are taking medications which inhibit peristaltic movement (e.g. opioids, loperamide.). If you have liver or gall bladder diseases, and/or intestinal obstruction, consult a health care practitioner prior to use. If you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema (swelling of hands, face, and feet) or are taking products containing diuretics, do not use this product.
Source
Official Health Canada record, licence 80079330
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging